Amedeo Smart

Free Medical Literature Service


 

Amedeo

Dermatology

  Free Subscription

12.09.2022

5 Am J Dermatopathol
2 Am J Pathol
3 BMC Cancer
18 Br J Dermatol
5 Cancer
1 Cancer Res
1 Clin Dermatol
25 Eur J Dermatol
2 Hum Mutat
2 Int J Dermatol
4 Intern Med
2 J Cutan Pathol
9 J Dermatol
3 J Invest Dermatol
2 N Engl J Med
1 Plast Reconstr Surg
7 PLoS One



    Am J Dermatopathol

  1. ISHIHARA Y, Ogita A, Ito K, Saeki H, et al
    Folliculosebaceous Cystic Hamartoma Arising in Miescher-Type Melanocytic Nevi.
    Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00083.
    >> Share

  2. STICOVA E, Hugo J, Gkalpakiotis S
    Dermatitis Herpetiformis With Flame Figures-An Unusual Case Description.
    Am J Dermatopathol. 2022 Sep 7. pii: 00000372-990000000-00087.
    >> Share

  3. MARK E, Sutton M, Gru A
    Primary Cutaneous Anaplastic Large-Cell Lymphoma With Aberrant CD20 Expression: Case Report and Review of the Literature.
    Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00081.
    >> Share

  4. ZIPPERER K, Good AJ, Gibson BR, Goodwin B, et al
    Cutaneous Malignant Squamomelanocytic Tumor: A Case Report of a Rare Neoplasm.
    Am J Dermatopathol. 2022 Sep 1. pii: 00000372-990000000-00080.
    >> Share

  5. ROBBINS QC, Schmieg J, Rush WL, Allbritton JI, et al
    A Rare Case of Monomorphic T-Cell Posttransplant Lymphoproliferative Disorder Presenting as Primary Cutaneous Anaplastic Large Cell Lymphoma, ALK Negative.
    Am J Dermatopathol. 2022 Aug 9. pii: 00000372-990000000-00072.
    >> Share


    Am J Pathol

  6. STUELTEN CH, Melis N, Subramanian B, Tang Y, et al
    Smurf2 regulates inflammation and collagen processing in cutaneous wound healing through TGF-beta/Smad3 signaling.
    Am J Pathol. 2022 Sep 2. pii: S0002-9440(22)00256.
    >> Share

  7. WANG Y, Mack JA, Hascall VC, Maytin EV, et al
    TGFbetaR mediated, p38MAPK dependent signaling drives enhanced myofibroblast differentiation during skin wound healing in mice lacking hyaluronan synthases 1 and 3.
    Am J Pathol. 2022 Sep 2. pii: S0002-9440(22)00257.
    >> Share


    BMC Cancer

  8. JIANG Y, Mason M, Cho Y, Chittiprolu A, et al
    Tolerance to oral anticancer agent treatment in older adults with cancer: a secondary analysis of data from electronic health records and a pilot study of patient-reported outcomes.
    BMC Cancer. 2022;22:950.
    >> Share

  9. WANG Y, Lu R, Chen P, Cui R, et al
    Promoter methylation of transient receptor potential melastatin-related 7 (TRPM7) predicts a better prognosis in patients with Luminal A breast cancers.
    BMC Cancer. 2022;22:951.
    >> Share

  10. PEPE FF, Cazzaniga ME, Baroni S, Riva F, et al
    Immunomodulatory effects of metronomic vinorelbine (mVRL), with or without metronomic capecitabine (mCAPE), in hormone receptor positive (HR+)/HER2-negative metastatic breast cancer (MBC) patients: final results of the exploratory phase 2 Victor-5 stu
    BMC Cancer. 2022;22:956.
    >> Share


    Br J Dermatol

  11. KIM RW, Barta K, Begolka WS, Capozza K, et al
    The quantitative impact of atopic dermatitis on caregivers across multiple life domains.
    Br J Dermatol. 2022 Sep 3. doi: 10.1111/bjd.21855.
    >> Share

  12. PUIG L
    Psoriasis treatment: no more room on the summit?
    Br J Dermatol. 2022 Sep 5. doi: 10.1111/bjd.21848.
    >> Share

  13. HASAN ZU, Ahmed I, Matin RN, Homer V, et al
    Topical treatment of actinic keratoses in organ transplant recipients: a feasibility study for SPOT (Squamous cell carcinoma Prevention in Organ transplant recipients using Topical treatments).
    Br J Dermatol. 2022;187:324-337.
    >> Share

  14. FRITSCHE M, Okun M, Kirby JS
    Damage in hidradenitis suppurativa: a narrative review emphasizing the need for a novel outcome measure.
    Br J Dermatol. 2022;187:288-294.
    >> Share

  15. CHEN F, Deng D, Pan C, Yao Z, et al
    Detection and characterization of low-level mosaicism among clinically unaffected parents of 'sporadic' epidermolysis bullosa simplex cases.
    Br J Dermatol. 2022;187:441-443.
    >> Share

  16. JIANG SW, Kwock JT, Liu B, Petty AJ, et al
    High-dose, high-frequency ustekinumab therapy for patients with severe hidradenitis suppurativa.
    Br J Dermatol. 2022;187:417-419.
    >> Share

  17. GRINNELL M, Keyes E, Diaz D, Vazquez T, et al
    Mycophenolate mofetil and methotrexate efficacy in dermatomyositis.
    Br J Dermatol. 2022;187:437-438.
    >> Share

  18. KLEIN B, Treudler R, Dumann K, Boldt A, et al
    Clinical response of CARD14-associated papulosquamous eruption to an anti-interleukin-17A antibody.
    Br J Dermatol. 2022;187:419-422.
    >> Share

  19. MERHI R, Canu D, Barnetche T, Duchez E, et al
    Assessment of Vitiligo Area Scoring Index (VASI), Facial-VASI and Vitiligo Extent Score using standardized photography of patients with vitiligo.
    Br J Dermatol. 2022;187:422-424.
    >> Share

  20. PENNITZ A, Kinberger M, Avila Valle G, Passeron T, et al
    Self-applied topical interventions for melasma: a systematic review and meta-analysis of data from randomized, investigator-blinded clinical trials.
    Br J Dermatol. 2022;187:309-317.
    >> Share

  21. DI CESARE A, Nikolakis G, Kanni T, Giamarellos-Bourboulis EJ, et al
    Identification of clinical features affecting diagnostic delay in paediatric hidradenitis suppurativa: results from a multicentre observational study.
    Br J Dermatol. 2022;187:428-430.
    >> Share

  22. GARG A, Krueger JG
    Raising the bar for efficacy in hidradenitis suppurativa: a rationale for combination targeted therapies.
    Br J Dermatol. 2022;187:414-415.
    >> Share

  23. CHANG R, Lai CC, Hung YM, Wang SI, et al
    Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data'.
    Br J Dermatol. 2022;187:450.
    >> Share

  24. FAZEL S, Paljarvi T
    Response to 'Isotretinoin and adverse neuropsychiatric outcomes: retrospective cohort study using routine data': reply from authors.
    Br J Dermatol. 2022;187:450-451.
    >> Share

  25. AARTS P, van der Zee HH
    Damage in hidradenitis suppurativa: receiving the deserved attention.
    Br J Dermatol. 2022;187:282-283.
    >> Share

  26. GOULDEN V, Ling TC, Babakinejad P, Dawe R, et al
    British Association of Dermatologists and British Photodermatology Group guidelines for narrowband ultraviolet B phototherapy 2022.
    Br J Dermatol. 2022;187:295-308.
    >> Share

  27. PAVLOVSKY M, Peled A, Sarig O, Astman N, et al
    Coexistence of pachyonychia congenita and hidradenitis suppurativa: more than a coincidence.
    Br J Dermatol. 2022;187:392-400.
    >> Share

  28. APFELBACHER C
    Closing a gap: an investigator global assessment for use in hidradenitis suppurativa clinical trials.
    Br J Dermatol. 2022;187:e79.
    >> Share


    Cancer

  29. LEHRER S, Rheinstein PH
    Breast cancer and body weight changes of young women in the UK Biobank cohort.
    Cancer. 2022 Aug 9. doi: 10.1002/cncr.34423.
    >> Share

  30. JACOBS JM, Post K, Massad K, Horick NK, et al
    A telehealth intervention for symptom management, distress, and adherence to adjuvant endocrine therapy: A randomized controlled trial.
    Cancer. 2022;128:3541-3551.
    >> Share

  31. SOLDATO D, Havas J, Crane TE, Presti D, et al
    Coffee and tea consumption, patient-reported, and clinical outcomes in a longitudinal study of patients with breast cancer.
    Cancer. 2022 Aug 1. doi: 10.1002/cncr.34401.
    >> Share

  32. BARGON CA, Young-Afat DA, Ikinci M, Braakenburg A, et al
    Breast cancer recurrence after immediate and delayed postmastectomy breast reconstruction-A systematic review and meta-analysis.
    Cancer. 2022 Jul 27. doi: 10.1002/cncr.34393.
    >> Share

  33. SONDAK VK, Neves RI, Wuthrick EJ, Messina JL, et al
    Current and future approaches in the surgical management of T3b/T4 primary and locoregionally advanced melanoma.
    Cancer. 2022 Sep 6. doi: 10.1002/cncr.34449.
    >> Share


    Cancer Res

  34. SRIVASTAVA A, Tommasi C, Sessions D, Mah A, et al
    MAB21L4 Deficiency Drives Squamous Cell Carcinoma via Activation of RET.
    Cancer Res. 2022;82:3143-3157.
    >> Share


    Clin Dermatol

  35. REHMAN S, Iqbal Z, Qureshi R, Rahman IU, et al
    Ethnic Practices in Treating Skin Diseases: The Traditional Dermatologist's Role.
    Clin Dermatol. 2022 Sep 4. pii: S0738-081X(22)00121.
    >> Share


    Eur J Dermatol

  36. SILLER A JR, Tyring SK, Harter NN
    Infantile transient smooth muscle contraction of the skin
    Eur J Dermatol. 2022;32:431.
    >> Share

  37. ANDRE R, Ram-Wolff C, Bagot M
    Clinical characteristics of Mycosis fungoides palmaris et plantaris: two cases and a systematic literature review
    Eur J Dermatol. 2022;32:421-423.
    >> Share

  38. ALRASHDAN MS, Kamaguchi M
    Management of mucous membrane pemphigoid: a literature review and update
    Eur J Dermatol. 2022;32:312-321.
    >> Share

  39. GUILLON C, Meziani M, Abdelli S, Sigaudo Roussel D, et al
    The aryl hydrocarbon receptor pathway plays a central role in the cutaneous response to pollutants
    Eur J Dermatol. 2022;32:305-311.
    >> Share

  40. QIN H, Liu N, Hu Y, Yu N, et al
    Safety and efficacy of secukinumab in psoriasis patients infected with hepatitis B virus: a retrospective study
    Eur J Dermatol. 2022;32:394-400.
    >> Share

  41. JUZOT C, Isvy-Joubert A, Khammari A, Knol AC, et al
    Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma
    Eur J Dermatol. 2022;32:401-407.
    >> Share

  42. REPOUSI N, Fotiadou S, Chaireti E, Makris G, et al
    Circadian cortisol profiles and hair cortisol concentration in patients with psoriasis: associations with anxiety, depressive symptomatology and disease severity
    Eur J Dermatol. 2022;32:357-367.
    >> Share

  43. BARRE M, Amatore F, Avenin M, Gorvel L, et al
    Occurrence of Sezary syndrome following the initiation of anti-IL-5 treatment
    Eur J Dermatol. 2022;32:419-420.
    >> Share

  44. KIMURA R, Sugita K, Horie T, Yamamoto O, et al
    Dual role of basophils in the pathogenesis of bullous pemphigoid elucidated by pathological and ultrastructural studies
    Eur J Dermatol. 2022;32:322-333.
    >> Share

  45. PRUGNIT-ROUANET M, Delaumenie S, Couraud A, Audevard D, et al
    Gliptin-induced bullous pemphigoid: withdrawal of gliptin allows for faster control of the disease
    Eur J Dermatol. 2022;32:368-372.
    >> Share

  46. FUKUZONO M, Okiyama N, Iwasaki R, Endo R, et al
    Intravenous immunoglobulin-induced thrombocytopenia: a case report and review of the literature
    Eur J Dermatol. 2022;32:373-376.
    >> Share

  47. VAZQUEZ-LOPEZ F, Carrero Martin J, Gomez de Castro C, Vivanco-Allende B, et al
    Spectrum of comorbid autoimmune diseases in patients with chondrodermatitis nodularis helicis: a 17-year retrospective study of 215 patients in Asturias, northern Spain
    Eur J Dermatol. 2022;32:347-351.
    >> Share

  48. DOLEZALOVA K, Strachan T, Matej R, Ricna D, et al
    Manifestations of cutaneous mycobacterial infections in patients with inborn errors of IL-12/IL-23-IFNgamma immunity
    Eur J Dermatol. 2022;32:1-10.
    >> Share

  49. MORI S, Makino T, Shimizu T
    Localized cutaneous nodular amyloidosis associated with Sjogren's syndrome and thymoma
    Eur J Dermatol. 2022;32:408-410.
    >> Share

  50. BAKLOUTI M, Sellami K, Turki H
    sQuiz your knowledge! Vesicles of the thighs weeping a milky white fluid
    Eur J Dermatol. 2022;32:432-433.
    >> Share

  51. NAVARRO M, Le Helloco C, Leducq S
    sQUIZ your knowledge! Painful toe ulcers in a 79-year-old woman
    Eur J Dermatol. 2022;32:430.
    >> Share

  52. REIS J, Nogueira M, Figueiras O, Coelho A, et al
    Pemphigus foliaceous after mRNA COVID-19 vaccine
    Eur J Dermatol. 2022;32:428-429.
    >> Share

  53. FUJISHIMA C, Munemoto S, Hioki C, Sasaki H, et al
    Successful dupilumab therapy for atopic dermatitis in a patient with X-linked agammaglobulinaemia
    Eur J Dermatol. 2022;32:416-417.
    >> Share

  54. WATABE D, Tsunoda K, Amano H
    Psoriatic arthritis flare-up after a second dose of BNT162b2 COVID-19 mRNA vaccine
    Eur J Dermatol. 2022;32:420-421.
    >> Share

  55. NAKAGAWA M, Hanada M, Amano H
    Allergic contact stomatitis caused by (meth)acrylates following sensitization by artificial nails, 20 years previously
    Eur J Dermatol. 2022;32:413-415.
    >> Share

  56. ROLO DE MATOS P, Nogueira A, Gomes N, Costa C, et al
    Rare presentation of Wells syndrome mimicking angioedema: a case report
    Eur J Dermatol. 2022;32:411-413.
    >> Share

  57. ULDAHL A, Sterner T, Bruze M, Dahlin J, et al
    Atopy patch testing and associations with atopic conditions and specific IgE tests: a population-based study in adolescents
    Eur J Dermatol. 2022;32:384-393.
    >> Share

  58. TANEMURA A, Mori S, Tonomura K, Yokoi K, et al
    Successful hybrid grafting of autologous cultured epidermis carrying a revertant mutation and split mesh skin in a patient with recessive dystrophic epidermolysis bullosa
    Eur J Dermatol. 2022;32:417-419.
    >> Share

  59. YANG L, Wang T, Liu YH
    A Chinese case of amelanotic lentigo maligna melanoma
    Eur J Dermatol. 2022;32:410-411.
    >> Share

  60. DARLENSKI R, Cherkezov D, Bogdanov I
    Prolonged but not short exposure to the climate in Antarctica is associated with increased skin barrier permeability, erythema, and pigmentation
    Eur J Dermatol. 2022;32:334-337.
    >> Share


    Hum Mutat

  61. XIA B, Biswas K, Foo TK, Gomes TT, et al
    Rare germline variants in PALB2 and BRCA2 in familial and sporadic chordoma.
    Hum Mutat. 2022;43:1396-1407.
    >> Share

  62. PEREZ-BECERRIL C, Wallace AJ, Schlecht H, Bowers NL, et al
    Screening of potential novel candidate genes in schwannomatosis patients.
    Hum Mutat. 2022;43:1368-1376.
    >> Share


    Int J Dermatol

  63. PARK A, Wong L, Lang A, Kraus C, et al
    Cutaneous T-cell lymphoma following dupilumab use: a systematic review.
    Int J Dermatol. 2022 Sep 8. doi: 10.1111/ijd.16388.
    >> Share

  64. KUSSINI J, Charalambous A, Sachsenweger F, Steinert M, et al
    Successful removal of anthralin staining from facial skin.
    Int J Dermatol. 2022 Sep 8. doi: 10.1111/ijd.16405.
    >> Share


    Intern Med

  65. MORIMOTO T, Yamasaki K, Isoshima Y, Yatera K, et al
    Avelumab-induced Pneumonitis in Metastatic Merkel Cell Carcinoma.
    Intern Med. 2022;61:2697-2698.
    >> Share

  66. SHINZAWA T, Usui I, Hanawa K, Kajitani H, et al
    Acute Exacerbation of Anemia with Parvovirus B19 Infection One Year after Sleeve Gastrectomy for Severe Obesity.
    Intern Med. 2022;61:2631-2635.
    >> Share

  67. ADACHI-KATAYAMA M, Kondo Y, Okamoto S, Sato R, et al
    Synovitis-acne-pustulosis-hyperostosis-osteitis Syndrome with Bilateral Pleural Effusion.
    Intern Med. 2022;61:2671-2675.
    >> Share

  68. SHIMAZAKI R, Sugaya K
    Difference between the MRI Findings for Neuro-Behcet Disease and Neuro-Sweet Disease.
    Intern Med. 2022;61:2701.
    >> Share


    J Cutan Pathol

  69. KITZ R, Leung O, Royer M
    A Rapidly Growing Cutaneous Malignant Glomus Tumor with a CCND3 Mutation.
    J Cutan Pathol. 2022 Sep 4. doi: 10.1111/cup.14324.
    >> Share

  70. SAUVAGEAU AP, Oulee A, Huang YY, Patel RM, et al
    Cutaneous Sarcoidosis Mimicking Pigmented Purpuric Dermatosis.
    J Cutan Pathol. 2022 Sep 7. doi: 10.1111/cup.14326.
    >> Share


    J Dermatol

  71. HIRATA Y, Shiiya C, Miyamoto J, Saito M, et al
    Congenital curved nail of the fourth toe: Report of three cases and review of the literature.
    J Dermatol. 2022;49:925-927.
    >> Share

  72. LEEYAPHAN C, Nanchaipruek Y, Phinyo P
    Therapeutic outcomes and prognostic factors in patients with hypertrophic herpes simplex infection treated with imiquimod: A systematic review and meta-analysis of individual patient data from case reports and case series.
    J Dermatol. 2022;49:879-886.
    >> Share

  73. TORII H, Kishimoto M, Tanaka M, Noguchi H, et al
    Patient perceptions of psoriatic disease in Japan: Results from the Japanese subgroup of the Understanding Psoriatic Disease Leveraging Insights for Treatment (UPLIFT) survey.
    J Dermatol. 2022;49:818-828.
    >> Share

  74. JAWORSKA K, Slawinska M, Wyszomirski A, Lakomy J, et al
    Dermoscopic features of eyelid margin tumors: A single-center retrospective study.
    J Dermatol. 2022;49:851-861.
    >> Share

  75. HUANG L, Zhang J, Chen F, Zhang X, et al
    The first case of Chinese phacomatosis pigmentokeratotica diagnosed by a missense HRAS mosaicism.
    J Dermatol. 2022;49:921-924.
    >> Share

  76. CHAO YC, Hong JB, Liu C, Lee MS, et al
    COL7A1 G2287R mutation with two clinical phenotypes in the same family: Bullous dermolysis of the newborn and dystrophic epidermolysis bullosa pruriginosa.
    J Dermatol. 2022;49:e313-e314.
    >> Share

  77. MIZUMAKI K, Makino S, Ikawa Y, Maeda S, et al
    Case of pembrolizumab-induced dermatomyositis with anti-transcription intermediary factor 1-gamma antibody.
    J Dermatol. 2022;49:e311-e312.
    >> Share

  78. TAKAMURA S, Teraki Y
    Treatment of bullous pemphigoid with dupilumab: Dupilumab exerts its effect by primarily suppressing T-helper 2 cytokines.
    J Dermatol. 2022;49:845-850.
    >> Share

  79. SHIBATA Y, Fukuda T, Nobeyama Y, Asahina A, et al
    Evaluation of nonalcoholic fatty liver disease in Japanese patients with psoriasis: Chest CT imaging for screening purposes.
    J Dermatol. 2022 Sep 8. doi: 10.1111/1346-8138.16564.
    >> Share


    J Invest Dermatol

  80. ZHU R, Yang H, Xue S, Fan Q, et al
    Intervening GSK3 Signaling Attenuates Cutaneous Inflammation and Itch in Mice: Implication for Future Therapeutic Development.
    J Invest Dermatol. 2022 Sep 1. pii: S0022-202X(22)01889.
    >> Share

  81. LASHERAS-OTERO I, Feliu I, Maillo A, Moreno H, et al
    The regulators of peroxisomal acyl-carnitine shuttle CROT and CRAT promote metastasis in melanoma.
    J Invest Dermatol. 2022 Sep 1. pii: S0022-202X(22)01890.
    >> Share

  82. AGELOPOULOS K, Renkhold L, Wiegmann H, Dugas M, et al
    Transcriptomic, epigenomic and neuro-anatomic signatures differ in chronic prurigo, atopic dermatitis and brachioradial pruritus.
    J Invest Dermatol. 2022 Sep 5. pii: S0022-202X(22)01895.
    >> Share


    N Engl J Med

  83. LANG DM
    Chronic Urticaria.
    N Engl J Med. 2022;387:824-831.
    >> Share

  84. CHRISTIAN NT, Borges VF
    What Dobbs Means for Patients with Breast Cancer.
    N Engl J Med. 2022 Aug 27. doi: 10.1056/NEJMp2209249.
    >> Share


    Plast Reconstr Surg

  85. MOELLHOFF N, Lettner M, Frank K, Giunta RE, et al
    Use of polylactid acid membrane improves outcome of split-thickness skin graft donor sites: a prospective, comparative, randomized study.
    Plast Reconstr Surg. 2022 Sep 1. pii: 00006534-990000000-01099.
    >> Share


    PLoS One

  86. VICENTE-MUNOZ S, Hunt BG, Lange TE, Wells SI, et al
    NMR-based metabolomic analysis identifies RON-DEK-beta-catenin dependent metabolic pathways and a gene signature that stratifies breast cancer patient survival.
    PLoS One. 2022;17:e0274128.
    >> Share

  87. RODARI G, Guez S, Salera S, Ulivieri FM, et al
    A single-centre study on predictors and determinants of pubertal delay and growth impairment in Epidermolysis Bullosa.
    PLoS One. 2022;17:e0274072.
    >> Share

  88. IWAI T, Hoshi M, Oebisu N, Takada N, et al
    Tumor-skin invasion is a reliable risk factor for poor prognosis in superficial soft tissue sarcomas.
    PLoS One. 2022;17:e0274077.
    >> Share

  89. PEREIRA ICF, Wyss HM, Pinchuk L, Beckers HJM, et al
    A model for designing intraocular pressure-regulating glaucoma implants.
    PLoS One. 2022;17:e0273672.
    >> Share

  90. BECKER JM, Holle H, van Ryckeghem DML, Van Damme S, et al
    No preconscious attentional bias towards itch in healthy individuals.
    PLoS One. 2022;17:e0273581.
    >> Share

  91. LI D, Li J, Yuan Y, Zhou J, et al
    Risk factors and prognosis of acute lactation mastitis developing into a breast abscess: A retrospective longitudinal study in China.
    PLoS One. 2022;17:e0273967.
    >> Share

  92. VAN GOGH S, Mukherjee S, Xu J, Wang Z, et al
    Iterative phase contrast CT reconstruction with novel tomographic operator and data-driven prior.
    PLoS One. 2022;17:e0272963.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016